PBI takes part in the THANZ Scientific Workshop

As well as working as a research scientist for PBI, Grace Gilmore is the local organising committee member for THANZ (Thrombosis & Haemostasis Society) and played the part of welcoming a wonderful group of expert speakers to the event recently. Read more

Non-Hodgkin lymphoma study published in The Lancet Oncology

Professor Ross Baker and the Perth Blood Institute’s Clinical Trials Unit have been part of the team to find a treatment to improve progression free survival in patients with relapsed indolent non-Hodgkin lymphoma. This publication is an interim analysis of the findings from a double-blind, randomised, placebo-controlled trial involving 186 academic medical centres throughout the world. Read more

PBI joins the Western Australian Health Translation Network

We are delighted to announce we have recently joined the Western Australian Health Translation Network (WAHTN). Read more

The Lancet publishes Multiple Myeloma clinical trial

Perth Blood Institute’s (PBI) Clinical Trials team played an instrumental role in the publication of findings for an important multicentre, open-label, randomised phase 3 trial for relapsed multiple myeloma. The results of the study were published in the highly prestigious peer-reviewed journal, The Lancet. Read more

ATAGI & THANZ COVID-19 Vaccine Statement

For the latest COVID 19 Australian Vaccination information read the joint statement from ATAGI and THANZ on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca. Read more

Science on the Swan 2021 Conference Presentation

Professor Ross Baker spoke on the topic of ‘WA Research Response to COVID-19’ at the Science on the Swan health and medical research conference on Monday. Read more

‘Thrombosis and Haemostasis’ Research Published

Murdoch University PhD student Jiayin (Munik) Tian has been selected to publish her research in ‘Thrombosis and Haemostasis’, the International Journal for Vascular Biology and Medicine. Read more

Symptoms of VTE after COVID 19 vaccination

The European Medicines Agency (EMA) has released further information and advice concerning the AstraZeneca vaccine and thrombosis and bleeding. Read more

A message from our CEO

One year ago the World Health Organization (WHO) announced that the novel coronavirus was a Public Health Emergency of international concern, identifying the spread of the disease as a pandemic. I would like to thank our supporters for continuing to support our organisation during these challenging times. Read more

Celebrating International Women's Day

To celebrate International Women's Day we interviewed our Research Nurse/Clinical Trial Coordinator, Shona. Shona talks about her role and the important people who have inspired her to take this path. Read more

Thrombosis Australia

Australians now have access to a central resource ‘hub’ of authoritative information to increase awareness and understanding of deep vein thrombosis, pulmonary embolism and stroke, and improve their prevention, early detection and management. Read more

Breakthrough for haemophilia A patients

Perth Blood Institute has participated in a ground-breaking clinical trial which has uncovered a new life-changing treatment for people with haemophilia. Read more

Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk. Read more

COVID-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them. Read more

Pancreatic Cancer study published

Pancreatic cancer is one of the deadliest diseases. A recent study led by PBI Scientist Dr Omar Elaskalani has been published in a special issue of Cancers by MDPI, a peer-reviewed academic journal. The study offers promising evidence that a commonly used blood thinner may help pancreatic cancer patients. Read more

Hands-on Medical Science Encounter

PBI conducted a laboratory workshop for year 11 high school students thinking about a career in science on 12 October 2019. This hands- on workshop enabled students to conduct experiments on flow cytometry and ABO blood group typing as well as find out why people bleed. Read more

World Haemophilia expert presents at PBI Education Dinner

PBI was fortunate to have renowned haemophilia expert Professor Midori Shima of Japan present his research findings at the PBI Education Dinner held on Saturday 19th October 2019 at the Parmelia Hilton Perth Hotel. Read more

Omar Elaskalani receives 2019 THANZ Award

Congratulations to PBI Research Scientist Omar Elaskalani, winner of the 2019 THANZ medal for best presentation at the recent Blood 2019 Conference held in Perth. Omar’s research outcomes will influence treatment options for patients in the future. Read more